Purpura, thrombocytopenic, idiopathic
Clinical trials for Purpura, thrombocytopenic, idiopathic explained in plain language.
Never miss a new study
Get alerted when new Purpura, thrombocytopenic, idiopathic trials appear
Sign up with your email to follow new studies for Purpura, thrombocytopenic, idiopathic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Low-Dose booster keep platelets up in ITP?
Disease control CompletedResearchers test whether giving low-dose rituximab after an initial treatment can make the response last longer in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The trial enrolls adults whose ITP has not responded well to steroi…
Matched conditions: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
Phase 3 • Sponsor: Ostfold Hospital Trust • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New combo therapy shows promise for Steroid-Resistant ITP
Disease control CompletedThis completed phase 3 trial tested whether adding all-trans retinoic acid (ATRA) to eltrombopag works better than eltrombopag alone for adults with immune thrombocytopenia (ITP) that did not respond to steroids. The study enrolled 96 participants and measured sustained platelet …
Matched conditions: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
Phase 3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC